What to Look for in a GLP-1 Weight Loss Provider in Chattanooga
I’m an emergency and Family Medicine physician in Chattanooga, Tennessee, and founder of Summit Metabolic Health. I read every patient chart personally. This article reports on a topic patients keep asking about — it is education, not an endorsement.
If you’re in Chattanooga searching for a GLP-1 provider, every option looks the same on the surface — a form, a vial, a monthly charge. They are not the same underneath. Some run your intake through an algorithm and ship a dose. Others have a physician reading your chart before every change they make. I’m Dr. Paul Miranda, board-certified, and I practice telehealth weight-loss medicine from right here in Chattanooga. I review every chart at Summit myself — not a nurse queue, not a script a computer picked for you. Here’s the exact checklist I’d want my own family to run before choosing a GLP-1 provider.
The search results for “GLP-1 provider” split two ways, and neither tells you what you actually need to know. One set is generic checklist content that never names a single company. The other is the companies themselves, and a company page is never going to tell you where its own model is weak. So the split you actually need to understand is simpler: physician-led, where a doctor reviews your history and adjusts your plan as you go, and algorithm-driven, where a questionnaire routes you to a fixed dosing path and a prescriber signs off on volume. Some companies even blend the language — claiming “physician-led” while building a business model that depends on you never leaving. I’ll name names below, because the differences are documented and they matter for a medication this powerful.
This is the first thing to check, and it’s not a formality. In the STEP 1 trial, patients on semaglutide 2.4mg lost 14.9% of body weight on average over 68 weeks, against 2.4% on placebo (NEJM, Wilding et al., 2021). In SURMOUNT-1, tirzepatide at the 15mg dose produced up to 20.9% loss over 72 weeks (NEJM, Jastreboff et al., 2022). Those numbers only happen when someone is actually adjusting your dose against your side effects and your response — titrating up when you’re tolerating it, holding or stepping back when you’re not. A fixed algorithm path can’t do that. It can only move you along a schedule.
It also matters before you start. SELECT showed a 20% reduction in major cardiovascular events in patients with established cardiovascular disease on semaglutide (NEJM, Lincoff et al., 2023) — which argues for real risk screening by someone who can read your history, not a checkbox form that can’t ask a follow-up question.
So ask directly: who looks at your chart, and do they change anything based on what’s in it? I’ve written up how this plays out with Henry Meds’ subscription model — a national telehealth operator built around compounded tiers, with no chart-review visit built into the flow. Ro and Hims/Hers run a similar structure: an intake questionnaire routes you to a prescriber who approves a plan at volume, not a physician who sat with your specific history. That’s intake-driven care, not physician-led care, regardless of what the landing page calls it.
Pricing is where the “physician-led” label gets tested hardest. Found advertises itself as physician-led, and the claim has a catch most people don’t see until checkout: a 12-month prepay, or a $289-a-month plan if you won’t commit up front. That’s not transparent pricing — that’s a lock-in dressed as a membership.
The DTC numbers I track regularly tell a similar story. Ro runs close to $498 a month all-in for its branded product. Hims is around $448 a month for branded semaglutide only, after exiting the compounded market earlier this year — I broke down exactly what that shift costs a patient in Ro vs. compounded semaglutide. Henry Meds sits lower on paper, $297 to $449 a month across compounded tiers, but that’s also the segment most exposed to the FDA’s 503B compounding rule changes — a tier that can be pulled or repriced on short notice.
Summit’s pricing is flat and disclosed before you start: $149, $99, or $399 depending on your plan, no 12-month prepay, no step-up cliff. You should be able to say, in one sentence, what you’ll pay in month six. If you can’t, that’s the answer to this criterion.
Almost nobody asks this one before they start, and it’s the question that matters most once you’re actually at goal weight. The trials are blunt about what happens when a GLP-1 is stopped cold: a large share of the lost weight comes back. A subscription-driven telehealth model has no financial reason to plan for your exit — your continued dose is their revenue. A program with no maintenance plan at all isn’t better; it just fails you later instead of now.
A real exit plan means your dose gets tapered down slowly, not stopped, to the lowest dose that still holds your weight — a floor that’s different for every patient, and for some people is genuinely zero. If a provider can’t describe what happens after you reach goal weight, you don’t have a plan. You have a prescription with an expiration date on your motivation.
This is the criterion DTC platforms built on a national intake queue can’t answer well. If you have a side effect at 9pm on a Tuesday, who actually responds, and do they know your history when they do? A support ticket routed to whoever’s on shift at a call center is not the same as a message to the physician who already knows your chart.
I practice telehealth from Chattanooga, in your time zone, and I’m the one reading the message when something’s off — not a queue. That’s a different kind of access than a DTC brand headquartered somewhere you’ve never been, answering through a generic support line. It’s worth asking any provider, directly: when something goes wrong, who answers, and have they seen my chart before?
Before you sign up anywhere, run the provider against these four questions:
– Chart review: Does a physician actually read your history and adjust your dose, or does an algorithm route you down a fixed path? – Pricing: Is the full monthly cost disclosed up front, with no prepay requirement and no pricing cliff three or six months in? – Exit plan: Can the provider describe, specifically, how your dose gets tapered once you reach goal weight? – Access: When something goes wrong, do you reach a person who already knows your case?
Summit Metabolic Health was built to answer yes to all four — flat $149/$99/$399 pricing, a physician on every chart, and a taper-based exit plan from day one. I also keep this kind of comparison updated as DTC pricing changes; you can read the rest of the backlog on the Summit blog.
Ready to start? Apply at summitmetabolichealth.com/apply.
This post is educational and does not replace individualized medical advice. Talk to a licensed physician about whether a GLP-1 medication is right for you.
